TABLE 2.
Performance of individual and combined recombinant Mycoplasma mycoides subsp. mycoides proteinsa
| Panel ID and serum category | No. of sera | No. (%) of sera testing positive or negative |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MSC_0136 |
MSC_0397 |
MSC_0636 |
MSC_0136/MSC_0397 |
MSC_0136/MSC_0636 |
|||||||
| Pos. | Neg. | Pos. | Neg. | Pos. | Neg. | Pos. | Neg. | Pos. | Neg. | ||
| Serum panel B (CBPP positive)b | 26 | 23 (88.5) | 3 (11.5) | 23 (88.5) | 3 (11.5) | 25 (96.2) | 1 (3.8) | 26 (100.0) | 0 (0.0) | 25 (96.2) | 1 (3.8) |
| Serum panel C | |||||||||||
| Outbreak | 43 | 40 (93.0) | 3 (7.0) | 13 (30.2) | 23 (69.8) | 39 (90.7) | 4 (9.3) | 40 (93.0) | 3 (7.0) | 41 (95.3) | 2 (4.6) |
| Preinfection | 7 | 1 (14.3) | 6 (85.7) | 0 (0.0) | 7 (100.0) | 0 (0.0) | 7 (100.0) | 2 (28.6) | 5 (71.4) | 1 (14.3) | 6 (85.7) |
| Acute stage | 21 | 1 (4.8) | 20 (95.2) | 2 (9.5) | 19 (90.5) | 5 (23.8) | 16 (76.2) | 2 (9.5) | 19 (90.5) | 6 (28.6) | 15 (71.4) |
| (1–22 dpi) | |||||||||||
| Postacute stage (23–238 dpi) | 35 | 35 (100.0) | 0 (0.0) | 20 (57.1) | 15 (42.9) | 12 (34.3) | 23 (65.7) | 35 (100.0) | 0 (0.0) | 35 (100.0) | 0 (0.0) |
a
This table represents results obtained through the use of panel B and C serum samples only. Pos., positive; Neg., negative.
b
All CBPP-negative samples (n = 21) from panel B were correctly identified as negative.